Table 3.
The prevalence of parasite infection and period prevalence of clinical cases for all study villages in 2017 (n = 34)
Outcome | Intervention | Control | Odds ratio (95% confidence interval) |
---|---|---|---|
Infection prevalencea | 1.8% (23/1259) | 2.4% (39/1638) | 0.54 (0.21, 1.37), p = 0.193 |
By age | |||
Under 5 years | 1.1% (2/191) | 3.7% (10/2720) | 024 (0.05, 1.31), p = 0.101 |
5–14 years | 1.7% (9/538) | 1.6% (11/698) | 0.91 (0.29, 2.81), p = 0.865 |
15–30 years | 3.0% (6/201) | 3.6% (9/252) | 0.64 (0.18, 2.31), p = 0.498 |
Above 30 years | 1.8% (6/333) | 2.1% (0/425) | 0.81 (0.23, 2.8), p = 0.734 |
Period prevalence of clinical malaria | 0.3% (12/3752) | 0.3% (18/6064) | 0.95 (0.30–2.97), p = 0.930 |
aRandom effects logistic regression models are not valid with a small number of clusters per arm so a t test on cluster level summaries was used; in these cases, a risk ratio is presented instead of an odds ratio